Interaction studies of novel cell selective antimicrobial peptides with model membranes and E. coli ATCC 11775

Biochimica et Biophysica Acta - Biomembranes

Volumn 1798, Issue 10, 2010, Pages 1864-1875

  Joshi, Seema ^a,b   Bisht, Gopal Singh ^a,b   Rawat, Diwan S ^b   Kumar, Anil ^a   Kumar, Rita ^a   Maiti, Souvik ^a   Pasha, Santosh ^a  

^a CSIR INSTITUTE OF GENOMICS AND INTEGRATIVE BIOLOGY   (India)

^b UNIVERSITY OF DELHI   (India)

Author keywords

Amphipathic; Antimicrobial peptides; Hemolytic activity; Membrane active; Microscopy

Indexed keywords

AMIKACIN; ANTIMICROBIAL PEPTIDE SA 1; ANTIMICROBIAL PEPTIDE SA 2; ANTIMICROBIAL PEPTIDE SA 3; ANTIMICROBIAL PEPTIDE SA 4; ANTIMICROBIAL PEPTIDE SA 5; ANTIMICROBIAL PEPTIDE SA 6; CALCEIN; CEFOPERAZONE; CEFOTAXIME; CIPROFLOXACIN; IMIPENEM; INDOLICIDIN; NETILMICIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; ANTIMICROBIAL CATIONIC PEPTIDE; LIPID BILAYER; PEPTIDE; PROTEIN BINDING;

ACINETOBACTER; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; ARTIFICIAL MEMBRANE; BACILLUS SUBTILIS; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; CIRCULAR DICHROISM; CONCENTRATION RESPONSE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CYTOPLASM; DNA BINDING; DRUG DESIGN; DRUG POTENCY; DRUG RESEARCH; ERYTHROCYTE; ESCHERICHIA COLI; FLOW CYTOMETRY; FLUORESCENCE ANALYSIS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HEMOLYSIS; HUMAN; HUMAN CELL; MEMBRANE BINDING; MEMBRANE DAMAGE; MEMBRANE STRUCTURE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN LIPID INTERACTION; PROTEIN TRANSPORT; PSEUDOMONAS AERUGINOSA; SCANNING ELECTRON MICROSCOPY; STAPHYLOCOCCUS AUREUS; TRANSMISSION ELECTRON MICROSCOPY; AMINO ACID SEQUENCE; ANIMAL; BOVINAE; CHEMISTRY; CONFOCAL MICROSCOPY; DRUG EFFECTS; LIPID BILAYER; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIAL VIABILITY; ULTRASTRUCTURE;

AMINO ACID SEQUENCE; ANIMALS; ANTI-INFECTIVE AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; CATTLE; CIRCULAR DICHROISM; ESCHERICHIA COLI; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; LIPID BILAYERS; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; MICROSCOPY, CONFOCAL; MICROSCOPY, ELECTRON, TRANSMISSION; PEPTIDES; PROTEIN BINDING;

BACTERIA (MICROORGANISMS); NEGIBACTERIA; POSIBACTERIA;

EID: 77955657627     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamem.2010.06.016     Document Type: Article

References (49)

1. Livermore D.M. Bacterial resistance: origin, epidemiology and impact. Clin. Infect. Dis. 2003, 36:11-23.
2. Sanchez J.S. Resistance to antibiotics. J. Bacteriol. 2006, 48:105-112.
3. Perez F., Hujer A.M., Hujer K.M., Decker B.K., Rather P.N., Bonomo R.A. Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob. Agents Chemother. 2007, 51:3471-3484.
4. Opar A. Bad bugs need more drugs. Nat. Rev. Drug Discov. 2007, 6:943-944.
5. Norrby S.R., Nord C.E., Finch R. Lack of development of new antimicrobial drugs: a potential serious threat to public health. Lancet Infect. Dis. 2005, 5:115-119.
6. Lai Y., Gallo AMPed R.L. up immunity: how antimicrobial peptides have multiple roles in immune defense. Trends Immunol. 2009, 3:131-141.
7. Hancock R.E.W., Scott M.G. The role of antimicrobial peptides in animal defenses. Proc. Natl Acad. Sci. U. S. A. 2000, 97:8856-8861.
8. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 2002, 415:389-395.
9. Hancock R.E.W., Chapple D.S. Peptide antibiotics. Antimicrob. Agents Chemother. 1999, 43:1317-1323.
10. Epand R.M., Vogel H.J. Diversity of antimicrobial peptides and their mechanisms of action. Biochim. Biophys. Acta 1999, 1462:11-28.
11. Giangaspero A., Sandri L., Tossi A. Amphipathic α helical antimicrobial peptides. Eur. J. Biochem. 2001, 268:5589-5600.
12. Glukhov E., Stark M., Burrows L.L., Deber C.M. Basis for selectivity of cationic antimicrobial peptides for bacterial versus mammalian membranes. J. Biol. Chem. 2005, 280:33960-33967.
13. Park K.H., Nan Y.H., Park Y., Kim J.I., Park I.S., Hahm K.S., Shin S.Y. Cell specificity, anti-inflammatory activity, and plausible bactericidal mechanism of designed Trp-rich model antimicrobial peptides. Biochim. Biophys. Acta 2009, 1788:1193-1203.
14. Zelezetsky I., Tossi A. Alpha-helical antimicrobial peptides-Using a sequence template to guide structure activity relationship studies. Biochim. Biophys. Acta 2006, 1758:1436-1449.
15. Brogden K.A. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?. Nat. Rev. Microbiol. 2005, 3:238-250.
16. Cudic M., Otvos L. Intracellular targets of antibacterial peptides. Curr. Drug Targets 2002, 3:101-106.
17. Ganz T. The role of antimicrobial peptides in innate immunity. Integr. Comp. Biol. 2003, 43:300-304.
18. Epand R.M., Epand R.F. Domains in bacterial membranes and the action of antimicrobial agents. Mol. Biosyst. 2009, 5:580-587.
19. Merrifield R.B. Solid phase synthesis. Science 1986, 232:341-347.
20. Chan B.P., Kwan S.Y., Matsuzaki K., Kim M.S., Kim S.C. Structure-activity analysis of buforin II, a histone H2A-derived antimicrobial peptide: The Proline hinge is responsible for the cell-penetrating ability of buforin II. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:8245-8250.
21. Wikler M.A., Low D.E., Cockerill F.R., Sheehan D.J., Craig W.A., Tenover F.C., Dudley M.N. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard-seventh edition. CLSI (formerly NCCLS) 2006, M7-A7.
22. Monroc S., Badosa E., Feliu L., Planas M., Montesinos E., Bardaji E. De novo designed cyclic cationic peptides as inhibitors of plant pathogenic bacteria. Peptides 2006, 27:2567-2574.
23. Mao D., Wallace B.A. Differential light scattering and absorption flattening optical effects are minimal in the circular dichroism spectra of small unilamellar vesicles. Biochemistry 1984, 23:2667-2673.
24. Zhu W.L., Song Y.M., Park Y., Park K.H., Yang S.T., Kim J., Park S., Hahm K.S., Shin S.Y. Substitution of the leucine zipper sequence in melittin with peptoid residues affects self-association, cell selectivity, and mode of action. Biochim. Biophys. Acta 2007, 1768:1506-1517.
25. Zhang L., Rozek A., Hancock R.E.W. Interaction of cationic antimicrobial peptides with model membranes. J. Biol. Chem. 2001, 276:35714-35722.
26. Bartlett G.R. Phosphorus assay in column chromatography. J. Biol. Chem. 1959, 234:466-468.
27. Chan D.I., Prenner E.J., Vogel H.J. Tryptophan- and arginine-rich antimicrobial peptides: structures and mechanisms of action. Biochim. Biophys. Acta 2006, 1758:1184-1202.
28. Chen Y.H., Yang J.T., Martinez H.M. Determination of secondary structure of proteins by circular dichroism and optical rotator dispersion. Biochemistry 1972, 11:4120-4123.
29. Tinoco L.W., da Silva A., Leite A., Valente A.P., Almeida F.C.L. NMR Structure of PW2 bound to SDS micelles: a tryptophan-rich anticoccidial peptide selected from phage display libraries. J. Biol. Chem. 2002, 277:36351-36356.
30. Schibli D.J., Hwang P.M., Vogel H.J. Structure of the antimicrobial peptide tritripticin bound to micelles: a distinct membrane-bound peptide fold. Biochemistry 1999, 38:16749-16755.
31. Torrent M., Sánchez D., Buzón V., Nogués M.V., Cladera J., Boix E. Comparison of the membrane interaction mechanism of two antimicrobial RNases: RNase 3/ECP and RNase 7. Biochim. Biophys. Acta 2009, 1788:1116-1125.
32. Chen Y.C., Mant T., Farmer S.W., Hancock R.E.W., Vasil M.L., Hodges R.S. Rational design of α-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index. J. Biol. Chem. 2005, 280:12316-12329.
33. Antcheva N., Morgera F., Creatti L., Vaccari L., Pag U., Pacor S., Shai Y., Sahl H.G., Tossi A. Artificial beta defensin based on a minimal defensin template. Biochem. J. 2009, 421:335-347.
34. Lee K.H., Lee D.G., Park Y., Kang D., Shin S.Y., Hahm K.S., Kim Y. Interactions between the plasma membrane and the antimicrobial peptide HP (2-20) and its analogues derived from Helicobacter pylori. Biochem. J. 2006, 394:105-114.
35. Zelezetsky I., Pacor S., Pag U., Papo N., Shai Y., Sahl H.G., Tossi A. Controlled alteratioof the shape and conformational stability of a-helical cell-lytic peptides: effect on mode of action and cell specificity. Biochem. J. 2005, 390:177-188.
36. Schibli D.J., Epand R.F., Vogel H.J., Epand R.M. Tryptophan rich antimicrobial peptides: comparative properties and membrane interactions. Biochem. Cell Biol. 2002, 80:667-677.
37. Jedlovsky P., Mezei M. Effect of cholesterol on the properties of phospholipid membranes 1.Structural features. J. Phys. Chem. B 2003, 107:5311-5321.
38. Ladokhin A.S., Selsted M.E., White S.H. CD spectra of indolicidin antimicrobial peptides suggest turns, not polyproline helix. Biochemistry 1991, 38:12313-12319.
39. Zhanga X., Oglȩckaa K., Sandgrenb S., Beltingb M., Esbjörnerc E.K., Nordénc B., Gräslund A. Dual functions of the human antimicrobial peptide LL-37-Target membrane perturbation and host cell cargo delivery. Biochim. Biophys. Acta 2009, Epub. 10.1016/j.bbamem.2009.12.011.
40. Rex S., Schwarz G. Quantitative studies on the melittin-induced leakage mechanism of lipid vesicles. Biochemistry 1998, 37:2336-2345.
41. Almeida P.F., Pokorny A. Mechanism of antimicrobial, cytolytic, and cell penetrating peptides: from kinetics to thermodynamics. Biochemistry 2009, 48:8083-8093.
42. Park S.C., Kim M.H., Hossain M.A., Shin S.Y., Kim Y., Stella L., Wade J.D., Park Y., Hahm K.S. Amphipathic alpha-helical peptide, HP (2-20), and its analogues derived from Helicobacter pylori: pore formation mechanism in various lipid compositions. Biochim. Biophys. Acta 2008, 1778:229-241.
43. s2-casein f(183-207) and effect on bacterial membranes and cell morphology. Biochim. Biophys. Acta 2008, 1778:2444-2449.
44. Hyde A.J., Parisot J., McNichol A., Bonev B.B. Nisin-induced changes in Bacillus morphology suggests a paradigm of antibiotic action. Proc. Natl. Acad. Sci. 2006, 103:19896-19901.
45. Friedrich C.L., Moyles D., Beveridge T.J., HANCOCK R.E.W. Antibacterial action of structurally diverse cationic peptides on gram-positive bacteria. Antimicrob. Agents Chemother. 2000, 44:2086-2092.
46. Park S.C., Kim J.Y., Shin S.O., Jeong C.Y., Kim M.H., Shin S.Y., Cheong G.W., Park Y., Hahm K.S. Investigation of toroidal pore and oligomerization by melittin using transmission electron microscopy. Biochem. Biophys. Res. Commun. 2006, 343:222-228.
47. Park C.B., Kim H.S., Kim S.C. Mechanism of action of the antimicrobial peptide Buforin II: Buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions. Biochem. Biophys. Res. Commun. 1998, 244:253-257.
48. Imura Y., Choda N., Matsuzaki K. Magainin 2 in action: distinct modes of membrane permeabilization in living bacterial and mammalian cells. Biophys. J. 2008, 95:5757-5765.
49. Yang S.T., Shin S.Y., Hahm K.S., Kim J.I. Different modes in antibiotic action of tritripticin analogs, cathelicidin-derived Trp-rich and Pro/Arg-rich peptides. Biochim. Biophys. Acta 2006, 1758:1580-1586.